EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer.

Varella-Garcia, M; Diebold, J; Eberhard, D A; Geenen, K; Hirschmann, A; Kockx, M; Nagelmeier, I; Rüschoff, J; Schmitt, M; Arbogast, S; Cappuzzo, F

Varella-Garcia, M; Diebold, J; Eberhard, D A; Geenen, K; Hirschmann, A; Kockx, M; Nagelmeier, I; Rüschoff, J; Schmitt, M; Arbogast, S; Cappuzzo, F.

Affiliation

Varella-Garcia M; University of Colorado Cancer Center, Aurora, Colorado 80045, USA. marileila.garcia@ucdenver.edu

J Clin Pathol ; 62(11): 970-7, 2009 Nov.

Article in En | MEDLINE | ID: mdl-19861557

Subject(s)

Biomarkers, Tumor/metabolism; Carcinoma, Non-Small-Cell Lung/diagnosis; ErbB Receptors/metabolism; Lung Neoplasms/diagnosis; Antineoplastic Agents/therapeutic use; Carcinoma, Non-Small-Cell Lung/drug therapy; Clinical Trials, Phase III as Topic; ErbB Receptors/antagonists & inhibitors; Humans; In Situ Hybridization, Fluorescence/methods; Lung Neoplasms/drug therapy; Neoplasm Proteins/metabolism; Practice Guidelines as Topic; Protein Kinase Inhibitors/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Non-Small-Cell Lung / ErbB Receptors / Lung Neoplasms Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Clin Pathol Year: 2009 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google